Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021
Corporate Participants:
Lavina Talukdar — Senior Vice President and Head of Investor Relations
Stephane Bancel — Chief Executive Officer
Corinne Le Goff — Chief Commercial Officer
David Meline — Chief Financial Officer
Stephen Hoge — President
Analysts:
Salveen Richter — Goldman Sachs — Analyst
Matthew Harrison — Morgan Stanley — Analyst
Edward Tenthoff — Piper Sandler — Analyst
Michael Yee — Jefferies — Analyst
Gena Wang — Barclays — Analyst
Geoffrey Meacham — Bank of America — Analyst
Cory Kasimov — J.P. Morgan — Analyst
Hartaj Singh — Oppenheimer & Co. — Analyst
Joseph Stringer — Needham & Company — Analyst
Mani Foroohar — SVB Leerink — Analyst
Simon Baker — Redburn — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
Listen On
